Merck & Co. (MRK)
(Real Time Quote from BATS)
$113.46 USD
+0.15 (0.13%)
Updated Aug 16, 2024 11:07 AM ET
3-Hold of 5 3
C Value C Growth D Momentum C VGM
Brokerage Reports
Merck & Co., Inc. [MRK]
Reports for Purchase
Showing records 241 - 260 ( 399 total )
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Comprehensive Technical and Fundamental Analysis for MRK
Provider: Stock Traders Daily
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Comprehensive Technical and Fundamental Analysis for MRK
Provider: Stock Traders Daily
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Comprehensive Technical and Fundamental Analysis for MRK.
Provider: Stock Traders Daily
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Comprehensive Technical and Fundamental Analysis for MRK.
Provider: Stock Traders Daily
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Immuno-Oncology Key Opinion Leader Conference Call Recap
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R